Longboard Pharmaceuticals Overview

Longboard Pharmaceuticals Other Income Expense Net

Other Income/Expense Net for LBPH.

Quarterly Other Income/Expense

$3.58M

↑ 453.09% YoY

As of Sep 30, 2024

Annual Other Income/Expense (TTM)

$10.54M

↑ 593.81% YoY

Trailing 12 months ending Sep 30, 2024

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin